Literature DB >> 30660866

Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line.

Benjamin Schmid1, Kennie R Prehn2, Natakarn Nimsanor3, Blanca Irene Aldana Garcia4, Ulla Poulsen2, Ida Jørring2, Mikkel A Rasmussen2, Christian Clausen2, Ulrike A Mau-Holzmann5, Sarayu Ramakrishna6, Ravi Muddashetty7, Rachel Steeg8, Kevin Bruce8, Peter Mackintosh8, Andreas Ebneth9, Bjørn Holst2, Alfredo Cabrera-Socorro9.   

Abstract

Alzheimer's disease (AD) is the most frequent neurodegenerative disease amongst the elderly. The SNPs rs429358 and rs7412 in the APOE gene are the most common risk factor for sporadic AD, and there are three different alleles commonly referred to as APOE-ε2, APOE-ε3 and APOE-ε4. Induced pluripotent stem cells (iPSCs) hold great promise to model AD as such cells can be differentiated in vitro to the required cell type. Here we report the use of CRISPR/Cas9 technology employed on iPSCs from a healthy individual with an APOE-ε3/ε4 genotype to obtain isogenic APOE-ε2/ε2, APOE-ε3/ε3, APOE-ε4/ε4 lines as well as an APOE-knock-out line.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30660866     DOI: 10.1016/j.scr.2018.11.010

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  10 in total

Review 1.  Dissecting the complexities of Alzheimer disease with in vitro models of the human brain.

Authors:  Joel W Blanchard; Matheus B Victor; Li-Huei Tsai
Journal:  Nat Rev Neurol       Date:  2021-11-08       Impact factor: 42.937

2.  APOE4 Affects Basal and NMDAR-Mediated Protein Synthesis in Neurons by Perturbing Calcium Homeostasis.

Authors:  Sarayu Ramakrishna; Vishwaja Jhaveri; Sabine C Konings; Bharti Nawalpuri; Sumita Chakraborty; Bjørn Holst; Benjamin Schmid; Gunnar K Gouras; Kristine K Freude; Ravi S Muddashetty
Journal:  J Neurosci       Date:  2021-09-02       Impact factor: 6.167

Review 3.  Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease.

Authors:  Madhumitha Katta; Blessy Aksa Mathew; Pragya Chaturvedi; Abhilash Ludhiadch; Anjana Munshi
Journal:  Neurol Sci       Date:  2022-09-06       Impact factor: 3.830

Review 4.  Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease.

Authors:  Tosha Williams; David R Borchelt; Paramita Chakrabarty
Journal:  Mol Neurodegener       Date:  2020-01-31       Impact factor: 18.879

5.  Microglia-like Cells Promote Neuronal Functions in Cerebral Organoids.

Authors:  Ilkka Fagerlund; Antonios Dougalis; Anastasia Shakirzyanova; Mireia Gómez-Budia; Anssi Pelkonen; Henna Konttinen; Sohvi Ohtonen; Mohammad Feroze Fazaludeen; Marja Koskuvi; Johanna Kuusisto; Damián Hernández; Alice Pebay; Jari Koistinaho; Tuomas Rauramaa; Šárka Lehtonen; Paula Korhonen; Tarja Malm
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

6.  APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes.

Authors:  Sherida M de Leeuw; Aron W T Kirschner; Karina Lindner; Ruslan Rust; Vanessa Budny; Witold E Wolski; Anne-Claude Gavin; Roger M Nitsch; Christian Tackenberg
Journal:  Stem Cell Reports       Date:  2021-12-16       Impact factor: 7.765

Review 7.  Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.

Authors:  Della Grace Thomas Parambi; Khalid Saad Alharbi; Rajesh Kumar; Seetha Harilal; Gaber El-Saber Batiha; Natália Cruz-Martins; Omnia Magdy; Arafa Musa; Dibya Sundar Panda; Bijo Mathew
Journal:  Mol Neurobiol       Date:  2021-10-15       Impact factor: 5.682

Review 8.  Human iPSC banking: barriers and opportunities.

Authors:  Ching-Ying Huang; Chun-Lin Liu; Chien-Yu Ting; Yueh-Ting Chiu; Yu-Che Cheng; Martin W Nicholson; Patrick C H Hsieh
Journal:  J Biomed Sci       Date:  2019-10-28       Impact factor: 8.410

Review 9.  EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines.

Authors:  Rachel Steeg; Sabine C Mueller; Nancy Mah; Bjørn Holst; Alfredo Cabrera-Socorro; Glyn N Stacey; Paul A De Sousa; Aidan Courtney; Heiko Zimmermann
Journal:  Stem Cell Reports       Date:  2021-08-10       Impact factor: 7.765

Review 10.  APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.

Authors:  Zonghua Li; Francis Shue; Na Zhao; Mitsuru Shinohara; Guojun Bu
Journal:  Mol Neurodegener       Date:  2020-11-04       Impact factor: 18.879

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.